Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

An enhanced bioluminescence-based Annexin V probe for apoptosis detection in vitro and in vivo.

Head T, Dau P, Duffort S, Daftarian P, Joshi PM, Vazquez-Padron R, Deo SK, Daunert S.

Cell Death Dis. 2017 May 25;8(5):e2826. doi: 10.1038/cddis.2017.141.

PMID:
28542141
2.

Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.

Zhou M, Yang H, Learned RM, Tian H, Ling L.

Nat Commun. 2017 May 16;8:15433. doi: 10.1038/ncomms15433.

PMID:
28508871
3.

US immigration order strikes against biotech.

Levin JM, Holtzman SH, Maraganore J, Hastings PJ, Cohen R, Dahiyat B, Adams J, Adams C, Ahrens B, Albers J, Aspinall MG, Audia JE, Babler M, Barrett P, Barry Z, Bermingham N, Bloch S, Blum RI, Bolno PB, Bonney MW, Booth B, Bradbury DM, Brauer SK, Byers B, Cagnoni PJ, Cali BM, Ciechanover I, Clark C, Clayman MD, Cleland JL, Cobb P, Cooper R, Currie MG, Diekman J, Dobmeier EL, Doerfler D, Donley EL, Dunsire D, During M, Eckstein JW, Elenko E, Exter NA, Fleming JJ, Flesher GJ, Formela JF, Forrester R, Francois C, Franklin H, Freeman MW, Furst H, Gage LP, Galakatos N, Gallagher BM, Geraghty JA, Gill S, Goeddel DV, Goldsmith MA, Gowen M, Goyal V, Graney T, Grayzel D, Greene B, Grint P, Gutierrez-Ramos JC, Haney B, Ha-Ngoc T, Harris T, Hasnain F, Hata YS, Hecht P, Henshaw L, Heyman R, Hoppenot H, Horvitz HR, Hughes TE, Hutton WS, Isaacs ST, Jenkins A, Jonker J, Kaplan J, Karsen P, Keiper J, Kim J, Kindler J, King R, King V, Kjellson N, Koenig S, Koenig G, Kolchinsky P, Laikind P, Langer RB, Lee JJ, Leff JS, Leicher BA, Leschly N, Levin A, Levin M, Levine AJ, Levy A, Liu DR, Lodish HF, Lopatin U, Love TW, Macdonald G, Maderis GJ, Mahadevia A, Mahanthappa NK, Martin JF, Martin A, Martucci WE, McArthur JG, McCann CM, McCarthy SA, McDonough CG, Mendlein J, Miller L, Miralles D, Moch KI, More B, Myers AG, Narachi MA, Nashat A, Nelson W, Newell WJ, Olle B, Osborn JE, Owens JC, Pande A, Papadopoulos S, Parker HS, Parmar KM, Patterson MR, Paul SM, Perez R, Perry M, Pfeffer CG, Powell M, Pruzanski M, Purcell DJ, Rakhit A, Ramamoorthi K, Rastetter W, Rawcliffe AA, Reid LE, Renaud RC, Rhodes JP, Rieflin WJ, Robins C, Rocklage SM, Rosenblatt M, Rosin JG, Rutter WJ, Saha S, Samuels C, Sato VL, Scangos G, Scarlett JA, Schenkein D, Schreiber SL, Schwab A, Sekhri P, Shah R, Shenk T, Siegall CB, Simon NJ, Simonian N, Stein J, Su M, Szela MT, Taglietti M, Tandon N, Termeer H, Thornberry NA, Tolar M, Ulevitch R, Vaishnaw AK, VanLent A, Varsavsky M, Vlasuk GP, Vounatsos M, Waksal SG, Warma N, Watts RJ, Werber Y, Westphal C, Wierenga W, Williams DE, Williams LR, Xanthopoulos KG, Zohar D, Zweifach SS.

Nat Biotechnol. 2017 Mar 7;35(3):204-206. doi: 10.1038/nbt.3824. No abstract available.

PMID:
28267733
4.

Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.

Zhou M, Luo J, Chen M, Yang H, Learned RM, DePaoli AM, Tian H, Ling L.

J Hepatol. 2017 Jun;66(6):1182-1192. doi: 10.1016/j.jhep.2017.01.027. Epub 2017 Feb 9.

5.

Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling.

Galon-Tilleman H, Yang H, Bednarek MA, Spurlock SM, Paavola KJ, Ko B, To C, Luo J, Tian H, Jermutus L, Grimsby J, Rondinone CM, Konkar A, Kaplan DD.

J Biol Chem. 2017 Feb 3;292(5):1925-1933. doi: 10.1074/jbc.M116.748103. Epub 2016 Dec 19.

PMID:
27994053
6.

Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions.

Lariosa-Willingham KD, Rosler ES, Tung JS, Dugas JC, Collins TL, Leonoudakis D.

BMC Res Notes. 2016 Sep 5;9(1):444. doi: 10.1186/s13104-016-2219-8.

7.

A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells.

Lariosa-Willingham KD, Rosler ES, Tung JS, Dugas JC, Collins TL, Leonoudakis D.

BMC Res Notes. 2016 Sep 5;9(1):419. doi: 10.1186/s13104-016-2220-2.

8.

Reproductive toxicity of brazilein in ICR mice.

Yuan ZY, Lei F, Chai YS, Wu H, Zhao S, Wang YG, Feng TS, Li HY, Li HY, Zhan HL, Xing DM, DU LJ.

Chin J Nat Med. 2016 Jun;14(6):441-8. doi: 10.1016/S1875-5364(16)30041-3.

PMID:
27473962
9.

Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance.

Starck SR, Shastri N.

Immunol Rev. 2016 Jul;272(1):8-16. doi: 10.1111/imr.12434. Review.

PMID:
27319338
10.

Development of a central nervous system axonal myelination assay for high throughput screening.

Lariosa-Willingham KD, Rosler ES, Tung JS, Dugas JC, Collins TL, Leonoudakis D.

BMC Neurosci. 2016 Apr 22;17:16. doi: 10.1186/s12868-016-0250-2.

11.

Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.

Zhou M, Learned RM, Rossi SJ, DePaoli AM, Tian H, Ling L.

Hepatology. 2016 Mar;63(3):914-29. doi: 10.1002/hep.28257. Epub 2015 Nov 30.

12.

Transportation of berberine into HepG2, HeLa and SY5Y cells: a correlation to its anti-cancer effect.

Pang YN, Liang YW, Feng TS, Zhao S, Wu H, Chai YS, Lei F, Ding Y, Xing DM, Du LJ.

PLoS One. 2014 Nov 17;9(11):e112937. doi: 10.1371/journal.pone.0112937. eCollection 2014.

13.

From Beta cell replacement to beta cell regeneration: implications for antidiabetic therapy.

Liu C, Wu H.

J Diabetes Sci Technol. 2014 Nov;8(6):1221-6. doi: 10.1177/1932296814540611. Epub 2014 Jun 22. Review.

14.

A nontumorigenic variant of FGF19 treats cholestatic liver diseases.

Luo J, Ko B, Elliott M, Zhou M, Lindhout DA, Phung V, To C, Learned RM, Tian H, DePaoli AM, Ling L.

Sci Transl Med. 2014 Jul 30;6(247):247ra100. doi: 10.1126/scitranslmed.3009098.

15.

Mesenchymal stem cell-based therapy for type 1 diabetes.

Wu H, Mahato RI.

Discov Med. 2014 Mar;17(93):139-43. Review.

16.

Restoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in Zucker fa/fa rats.

Jiao J, Bae EJ, Bandyopadhyay G, Oliver J, Marathe C, Chen M, Hsu JY, Chen Y, Tian H, Olefsky JM, Saberi M.

Diabetes. 2013 Apr;62(4):1074-83. doi: 10.2337/db12-0681. Epub 2012 Dec 17.

17.

Evaluating insulin secretagogues in a humanized mouse model with functional human islets.

Luo J, Nguyen K, Chen M, Tran T, Hao J, Tian B, Rulifson IC, Zhang Y, Tian L, Zhang Y, Lopez E, Lin DC, Wang Y, Ma Z, Houze J, Guo Z.

Metabolism. 2013 Jan;62(1):90-9. doi: 10.1016/j.metabol.2012.07.010. Epub 2012 Sep 13.

PMID:
22982177

Supplemental Content

Loading ...
Support Center